New treatments for chronic hepatitis C infection

Simple item page
dc.contributor.authorYapali, Suna
dc.contributor.authorTozun, Nurdan
dc.date.accessioned2023-02-21T12:32:26Z
dc.date.available2023-02-21T12:32:26Z
dc.date.issued2016-01-01
dc.description.abstractThe goal of HCV treatment is to prevent cirrhosis, hepatocellular carcinoma, liver-related deaths. The development of direct-acting antiviral (DAA) agents which target various steps in HCV lifecycle led to a revolution by providing nearly complete eradication of HCV. The new treatment regimens with high cure rates have changed the standards of care in the regions where patients have access to new treatments. This review addresses the recent updates in management of chronic hepatitis C infection.
dc.description.issue1
dc.description.pages43-49
dc.description.volume29
dc.identifier.doi10.5472/MMJsi.2901.09
dc.identifier.urihttps://hdl.handle.net/11443/1072
dc.identifier.urihttp://dx.doi.org/10.5472/MMJsi.2901.09
dc.identifier.wosWOS:000430068300007
dc.publisherMARMARA UNIV, FAC MEDICINE
dc.relation.ispartofMARMARA MEDICAL JOURNAL
dc.subjectHepatitis C
dc.subjectNew treatments
dc.subjectDirect antiviral agents
dc.titleNew treatments for chronic hepatitis C infection
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
New treatments for chronic hepatitis C infection.pdf
Size:
81.92 KB
Format:
Adobe Portable Document Format
Download

Collections

WOS